Search - tctmd.com

Displaying 1 - 9 of 9

Sort: Relevancy | Date

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for November 2025

Caitlin E. Cox

December 01, 2025

News Daily News PCR London Valves 2021

Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves

Michael O'Riordan

December 01, 2021

News Conference News TCT 2019

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Todd Neale

October 04, 2019

News Conference News TCT 2017

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Todd Neale

November 02, 2017

News Daily News

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Yael L. Maxwell

May 02, 2016

News Daily News

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Yael L. Maxwell

May 02, 2016

News Daily News

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

December 23, 2015

News Daily News

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Yael L. Maxwell

June 17, 2015

News Daily News

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Yael L. Maxwell

June 17, 2015

Advertisement

TCTMD’s Top 10 Most Popular Stories for November 2025

Cardiologist Tests Positive for Omicron COVID-19 After Trip to PCR London Valves

Watchman Adverse Events: Analysis Digs Into What’s Been Reported to the FDA

Longer-term Outcomes of Watchman Reassure as Debate Continues Over How It Should Be Used

Sluggish CMS Reimbursement Lags Cardiac Device Approvals: Should Value Endpoints be Added to Trials?

Los Lentos Reembolsos de los CMS Lastran las Aprobaciones de Dispositivos Cardíacos: ¿Deberían de Incorporarse a los Ensayos Puntos Finales sobre el Valor?

Year in Review: Physicians Select the Most Important News of 2015, in Interventional Cardiology and Beyond

Un Meta Análisis Revela que Watchman sigue Sin ser Inferior a Warfarina y Da Buenos Resultados de Seguridad

Meta-analysis Shows Watchman Still Noninferior to Warfarin, With Good Safety Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content